cyclosporine has been researched along with ST Elevation Myocardial Infarction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Amaz, C; Bergerot, C; Besseyre des Horts, T; Bière, L; Croisille, P; Cung, TT; de Poli, F; Derumeaux, G; Garcia-Dorado, D; Gilard, M; Hovasse, T; Jossan, C; Mewton, N; Meyer, E; Ovize, M; Pezel, T; Prunier, F; Roubille, F; Schaaf, M; Thibault, H | 1 |
Botker, HE; Engstrom, T; Erlinge, D; Garcia-Dorado, D; Hausenloy, DJ; Heusch, G; Ibanez, B; Kloner, RA; Ovize, M; Yellon, DM | 1 |
1 trial(s) available for cyclosporine and ST Elevation Myocardial Infarction
Article | Year |
---|---|
Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
Topics: Aged; Anterior Wall Myocardial Infarction; Cyclosporine; Double-Blind Method; Early Diagnosis; Female; France; Heart Disease Risk Factors; Humans; Injections, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Percutaneous Coronary Intervention; Predictive Value of Tests; Risk Assessment; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2020 |
1 other study(ies) available for cyclosporine and ST Elevation Myocardial Infarction
Article | Year |
---|---|
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
Topics: Adenosine; Cardiotonic Agents; Clinical Trials as Topic; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Enzyme Inhibitors; Humans; Hypothermia, Induced; Ischemic Postconditioning; Metoprolol; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide; Nitrites; Nucleotides, Cyclic; Oligopeptides; Oximes; Patient Selection; Protein Kinase C; Secosteroids; Signal Transduction; ST Elevation Myocardial Infarction; Vasodilator Agents | 2017 |